Sai Parenteral's Ltd. Listed
Incorporated in 2001, Sai Parenteral's Ltd. is a diversified pharmaceutical formulations company with expertise in research, development, and manufacturing.The company operates in two segments: Branded Generic...
GREY MARKET PREMIUM
+₹0
▲ +0.00% vs issue price
Issue Price
₹392.00
Est. Listing Price
₹392.00
Lot Size
38
Issue Details
Open Date
2026-03-24
Close Date
2026-03-27
Allotment
2026-03-30
Face Value
₹5.00
Total Issue Size
1,04,28,288 shares (agg. up to ₹409 Cr) Cr
Issue Type
Bookbuilding IPO
Exchange
NSE & BSE
Financials (₹ Cr)
| Period | Revenue | PAT | EBITDA | Net Worth |
|---|---|---|---|---|
| 30 Sep 2025 | 89.43 | 7.76 | 16.24 | 209.37 |
| 31 Mar 2025 | 163.74 | 14.43 | 39.44 | 95.78 |
| 31 Mar 2024 | 155.18 | 8.42 | 31.70 | 76.40 |
Key Ratios
Return on Equity
5.13
Return on Capital Employed
9.28
Return on Net Worth
5.09
PAT / Revenue
8.93
EBITDA / Revenue
18.68
EPS Pre-Issue
5.43
P/E Pre-Issue
72.19
Objects of the Issue
- Capacity expansion and upgradation of manufacturing facilities — ₹110.80 Cr
- Establishment of a new R&D Centre; — ₹18.02 Cr
- Repayment / prepayment of certain outstanding borrowings — ₹14.30 Cr
- Repayment / prepayment of certain outstanding borrowings — ₹33.00 Cr
- Investment in wholly owned subsidiary, Sai Parenterals Pte Limited (Singapore), in relation to the proposed acquisition of Noumed Pharmaceuticals Pty Limited (Australia); and — ₹35.64 Cr
- General corporate purposes
Lead Managers
Arihant Capital Markets Ltd.
Compare GMP Across IPOs
See how this IPO's GMP stacks up against every other live IPO.
Open GMP Charts →